Progressive markets

Sepsis Diagnostics Market: Global Analysis, Operation, Requirements, Region of Impact, Forecast to 2025

Sepsis Diagnostics Market Overview

 

Portland, OR -- (SBWIRE) -- 07/19/2017 -- Sepsis is a bloodstream infection in which there is a massive immune response and may lead to organ failure. The bloodstream infection arises from other organ infections such as skin, abdomen, lungs, and urinary tract. Patients with sepsis are treated in the intensive care unit and early treatment increases the chances of survival.

According to the center for disease control, in 2008, $14.6 billion was spent on hospitalization of sepsis patients. In most cases, sepsis is fatal and those who survive from sepsis may have permanent organ failure, physical disability, and cognitive impairment.

Diagnosis of sepsis is difficult as its signs and symptoms are like other infections. There are different tests for the confirmation of sepsis such as blood tests, urine test, wound secretion test, respiratory secretions, and imaging scans such as X-ray, CT scan, ultrasound, and magnetic resonance.

The global Sepsis Diagnostics Market is expected to grow at a CAGR of 9.2% from 2017 to 2025.

Sepsis Diagnostics Market By Product
-Blood Culture Media
-Instruments
-Assays & Reagents
-Software

Enquire About Report: https://www.progressivemarkets.com/enquiry-about-report/sepsis-diagnostics-market

Sepsis Diagnostics Market Dynamics:

for Sepsis Diagnostics industry Drivers:
- Increase in geriatric population.
- Rising number of hospital based infections.
- Increase in healthcare expenditure.
- Technological advancements.

for Sepsis Diagnostics industry Restraints:
- Shortage of skilled professionals.
- Lack of standard protocols for the diagnosis of sepsis.

Sepsis Diagnostics Market By Technology
- Immunoassays
- Flow Cytometry
- Microbiology
- Molecular Diagnostics

Sepsis Diagnostics Market Players:

The top players in the global sepsis diagnostics market include T2 Biosystems, Inc., bioMrieux SA, Thermo Fisher Scientific Inc., Cepheid, Nanosphere, Inc., Abbott Laboratories, Becton, Dickinson and Company, Roche Diagnostics Limited, Bruker Corporation, and Beckman Coulter, Inc.

Sepsis Diagnostics Market By Method
- Conventional Diagnostics
- Automated Diagnostics

Sepsis Diagnostics Market By Usability
- Laboratory Testing
- Point-of-care Testing

Sepsis Diagnostics Market By Pathogen
- Fungal Sepsis
- Bacterial Sepsis
- Gram-positive Bacterial Sepsis
- Gram-negative Bacterial Sepsis
- Others

Request Sample Report for Sepsis Diagnostics industry: https://www.progressivemarkets.com/request-sample/sepsis-diagnostics-market

Sepsis Diagnostics Market By Geography

-North America
U.S.
Canada
Mexico

-Europe
UK
Germany
France
Spain
Italy
Rest of Europe

-Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

-LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Table of Content For Sepsis Diagnostics Market

1. Executive summary for Sepsis Diagnostics industry
1.1. Key findings
1.2. Market attractiveness and trend analysis
1.3. Competitive landscape and recent industry development analysis

2. Introduction for Sepsis Diagnostics industry
2.1. Report description
2.2. Scope and definitions
2.3. Research methodology

3. Market landscape for Sepsis Diagnostics industry
3.1. Growth drivers
3.1.1. Impact analysis
3.2. Restrains and challenges
3.2.1. Impact analysis
3.3. Porter's analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global sepsis diagnostics market shares analysis, 2014-2025

Continue to Table of Content for Sepsis Diagnostics industry: https://www.progressivemarkets.com/industry-research/sepsis-diagnostics-market

List of Tables For Sepsis Diagnostics Market
Contain 57 Tables

List of Figures For Sepsis Diagnostics Market
Contain 55 Figures